Opaleye Management as of Sept. 30, 2022
Portfolio Holdings for Opaleye Management
Opaleye Management holds 42 positions in its portfolio as reported in the September 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Harrow Health (HROW) | 16.7 | $40M | 3.3M | 12.07 | |
| Ocular Therapeutix (OCUL) | 11.1 | $27M | 6.5M | 4.15 | |
| Rhythm Pharmaceuticals (RYTM) | 8.2 | $20M | 810k | 24.50 | |
| Tela Bio (TELA) | 7.2 | $17M | 2.0M | 8.52 | |
| Crinetics Pharmaceuticals In (CRNX) | 5.4 | $13M | 671k | 19.64 | |
| Cytokinetics Com New (CYTK) | 5.3 | $13M | 263k | 48.45 | |
| Keros Therapeutics (KROS) | 5.0 | $12M | 321k | 37.62 | |
| Protara Therapeutics Com Stk (TARA) | 3.3 | $8.0M | 2.7M | 2.95 | |
| Codexis (CDXS) | 2.9 | $7.0M | 1.2M | 6.06 | |
| Tracon Pharmaceuticals Com New | 2.9 | $7.0M | 4.2M | 1.67 | |
| Cutera (CUTR) | 2.8 | $6.7M | 148k | 45.60 | |
| Edgewise Therapeutics (EWTX) | 2.6 | $6.2M | 635k | 9.84 | |
| Mersana Therapeutics (MRSN) | 2.5 | $6.1M | 900k | 6.76 | |
| Larimar Therapeutics (LRMR) | 2.2 | $5.3M | 1.7M | 3.20 | |
| Eton Pharmaceuticals (ETON) | 2.2 | $5.3M | 2.5M | 2.10 | |
| Inhibrx | 2.2 | $5.3M | 293k | 17.95 | |
| Merus N V (MRUS) | 2.1 | $5.1M | 253k | 20.03 | |
| Vaxcyte (PCVX) | 1.9 | $4.6M | 190k | 24.00 | |
| Xoma Corp Del Com New (XOMA) | 1.8 | $4.4M | 248k | 17.91 | |
| Urogen Pharma (URGN) | 1.4 | $3.3M | 398k | 8.32 | |
| Liquidia Corporation Com New (LQDA) | 1.3 | $3.1M | 564k | 5.44 | |
| 4d Molecular Therapeutics In (FDMT) | 1.2 | $2.8M | 351k | 8.04 | |
| Stereotaxis Com New (STXS) | 1.2 | $2.8M | 1.6M | 1.80 | |
| Fortress Biotech | 1.1 | $2.6M | 3.0M | 0.86 | |
| Proqr Therapeutics Nv Shs Euro (PRQR) | 1.0 | $2.3M | 3.1M | 0.74 | |
| Graphite Bio | 0.8 | $1.8M | 577k | 3.17 | |
| Theseus Pharmaceuticals | 0.5 | $1.3M | 221k | 5.80 | |
| Impel Neuropharma | 0.5 | $1.2M | 255k | 4.87 | |
| Astria Therapeutics (ATXS) | 0.5 | $1.2M | 134k | 9.04 | |
| Modular Medical Com New (MODD) | 0.5 | $1.1M | 275k | 4.12 | |
| Allakos (ALLK) | 0.4 | $939k | 154k | 6.12 | |
| Chimerix (CMRX) | 0.3 | $704k | 365k | 1.93 | |
| Journey Med Corp (DERM) | 0.3 | $638k | 259k | 2.46 | |
| Morphosys Sponsored Ads (MOR) | 0.3 | $609k | 121k | 5.03 | |
| Edap Tms Sa Sponsored Adr (EDAP) | 0.2 | $588k | 71k | 8.25 | |
| Neuropace (NPCE) | 0.2 | $436k | 116k | 3.75 | |
| Lumos Pharma (LUMO) | 0.2 | $412k | 47k | 8.85 | |
| Neoleukin Therapeutics | 0.2 | $368k | 575k | 0.64 | |
| Optinose (OPTN) | 0.1 | $333k | 91k | 3.66 | |
| Meiragtx Holdings (MGTX) | 0.0 | $84k | 10k | 8.40 | |
| Ideaya Biosciences (IDYA) | 0.0 | $22k | 1.5k | 14.67 | |
| Biolinerx Sponsored Ads (BLRX) | 0.0 | $16k | 17k | 0.96 |
